Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin-Reference-Cited by-同舟云学术

Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin

Published:2017-09-30 Issue:1 Volume:97 Page:169-179
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kameda Kazuaki,Kako Shinichi,Hayakawa Jin,Akahoshi Yu,Komiya Yusuke,Harada Naonori,Ugai Tomotaka,Ishihara Yuko,Kawamura Koji,Sakamoto Kana,Sato Miki,Kanda Junya,Tanihara Aki,Wada Hidenori,Terasako-Saito Kiriko,Kimura Shun-ichi,Kikuchi Misato,Nakasone Hideki,Kanda Yoshinobu

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3141-4/fulltext.html

Reference24 articles.

1. Deeg HJ (2007) How I treat refractory acute GVHD. Blood 109:4119–4126. https://doi.org/10.1182/blood-2006-12-041889

2. Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in H, British Society for B, Marrow T (2012) Diagnosis and management of acute graft-versus-host disease. Br J Haematol 158:30–45. https://doi.org/10.1111/j.1365-2141.2012.09129.x

3. Cutler C, Antin JH (2016) Manifestations and treatment of acute graft-versus-host disease. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR (eds) Thomas’ hematopoietic transplantation, 5th edn. Wiley-Blackwell, Oxford, pp 1012–1019

4. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE et al (1990) A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 76:1464–1472

5. Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, Korbling M, Huh YO, Giralt S, Gajewski J, Donato M, Cleary K, Claxton D, Braunschweig I, van Besien K, Andersson BS, Anderlini P, Champlin R (1999) Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 94:1465–1470

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non‐relapse mortality after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2021-08-26

2. Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2020-09-16

3. Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post‐engraftment phase after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2020-07-06

4. Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation;Transplant Immunology;2020-02

5. Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation;Bone Marrow Transplantation;2018-08-31